Dimensional Fund Advisors
TRVI icon

Dimensional Fund Advisors’s Trevi Therapeutics TRVI Stock Holding History

Dimensional Fund Advisors’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Sell
16,101
-20,409
-56% -$228K ﹤0.01% 3071
2025
Q4 		$457K Sell
36,510
-4,933
-12% -$57K ﹤0.01% 2981
2025
Q3 		$379K Sell
41,443
-85,481
-67% -$641K ﹤0.01% 3036
2025
Q2 		$695K Hold
126,924
– – ﹤0.01% 2938
2025
Q1 		$799K Sell
126,924
-7,429
-6% -$35.4K ﹤0.01% 2921
2024
Q4 		$553K Buy
134,353
+62,143
+86% +$199K ﹤0.01% 3016
2024
Q3 		$241K Hold
72,210
– – ﹤0.01% 3140
2024
Q2 		$215K Buy
72,210
+49,475
+218% +$137K ﹤0.01% 3153
2024
Q1 		$78.4K Buy
+22,735
New +$50.7K ﹤0.01% 3290
2023
Q4 		– Sell
-18,382
Closed -$40.1K – 3456
2023
Q3 		$40.1K Buy
+18,382
New +$41.5K ﹤0.01% 3396

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return